|Bid||0.0000 x 0|
|Ask||0.0000 x 0|
|Day's Range||0.0000 - 0.0000|
|52 Week Range|
|PE Ratio (TTM)||-8.15|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
SAN DIEGO, Oct. 12, 2017 /PRNewswire/ -- Medical Marijuana, Inc. (MJNA), the first publicly traded cannabis company in the U.S., today announced that a recent clinical study conducted by renowned Mexico neurologist, Dr. Carlos G. Aguirre-Velazquez, successfully utilized its flagship THC-free product Real Scientific Hemp Oil-X™ (RSHO-X™). The study targeted the reduction in frequency, intensity and duration of convulsive crises in people with tuberous sclerosis complex (TSC) and saw promising results from cannabidiol (CBD) as a treatment for patients with TSC. The trial was comprised of patients with varying forms of epilepsy, with the majority having TSC, a genetic disorder characterized by the growth of noncancerous (benign tumors) in many parts of the body, including the brain, which can lead to convulsive crises.
SAN DIEGO, Oct. 11, 2017 /PRNewswire/ -- Medical Marijuana, Inc. (MJNA), the first-ever publicly traded cannabis company in the United States, announced today that it has expanded the size of its operations warehouse, more than tripling the size of the previous site. This expansion is a direct result of the rapid sales growth within the portfolio of companies, and with this growth over the coming months will come approximately 20 new employment opportunities at the operations facility. The most exciting thing about our new larger facilities and staff is we will be able to process as many as five times the number of orders than previously possible," said Medical Marijuana, Inc. Subsidiary Kannaway® CEO Blake Schroeder.
SAN DIEGO, Oct. 10, 2017 /PRNewswire/ --Medical Marijuana, Inc. (MJNA), the first publicly traded cannabis company in the United States, today announced that it will move forward with market expansion efforts in athletics with recent announcement by the World Anti-Doping Agency (WADA), the foundation initiated by the International Olympic Committee to coordinate and monitor drug use in sports, that cannabidiol (CBD) will be removed from its list of banned substances in 2018. Medical Marijuana, Inc.'s Real Scientific Hemp Oil-X™ (RSHO-X)™ CBD hemp oil, which is the only product on the market to be recognized by international governments to be completely free of tetrahydrocannabinol (THC), the well-known psychoactive compound in marijuana, is an ideal option for athletes looking to safely incorporate cannabinoids into their regimen.
SAN DIEGO , Oct. 6, 2017 /PRNewswire/ -- Medical Marijuana, Inc. (OTC: MJNA) announced today that subsidiary Kannaway LLC , the first hemp lifestyle network to offer cannabidiol (CBD) hemp botanical products, ...
SAN DIEGO, Oct. 5, 2017 /PRNewswire/ -- Medical Marijuana, Inc. (MJNA), the first-ever publicly traded cannabis company in the United States, today announced that Justin Stephens has joined subsidiary Kannaway® as Director of Member Support. In this new position, Stephens will be responsible for the management and development of the Kannaway® member support team. Kannaway's philosophy is to always put its customers and loyal Brand Ambassadors first. Justin will bring his years of expertise in the field to ensure that the company is delivering on this important value.
SAN DIEGO, Oct. 4, 2017 /PRNewswire/ -- Medical Marijuana, Inc. (MJNA), the first-ever publicly traded cannabis company in the United States, today announced that subsidiary HempMeds® will be participating in the 4th annual Boston CWCBE from October 5-6, 2017. Members of Medical Marijuana, Inc.'s executive team will be participating in the "Investing in Publicly Traded Companies" panel taking place on Thursday October 5, 2017 at 3:30 p.m. in room 109 at the John B. Hynes Convention Center in Boston. This panel will include the most up-to-date information about investing in publicly traded cannabis companies.
SAN DIEGO, Oct. 2, 2017 /PRNewswire/ -- Medical Marijuana, Inc. (MJNA), the first publicly traded cannabis company in the United States, today announced that its subsidiary HempMeds® Brasil is excited to support the establishment of the Associação Nacional dos usuários de Canabidiol (ANUC) Patient Association in Brazil dedicated to connecting patients with cannabis-friendly doctors and continuing to educate the Brazilian medical community and its citizens on the therapeutic uses of cannabis. The Company also applauds the appointment of Franklin Vargas as President of the Patient Association.